CTA
CRL icon

Colonial Trust Advisors’s Charles River Laboratories CRL Stock Holding History

Colonial Trust Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-77
Closed -$20.9K – 822
2024
Q1 		$20.9K Buy
77
+52
+208% +$12.4K ﹤0.01% 468
2023
Q4 		$5.91K Hold
25
– – ﹤0.01% 583
2023
Q3 		$4.9K Hold
25
– – ﹤0.01% 612
2023
Q2 		$5.26K Hold
25
– – ﹤0.01% 621
2023
Q1 		$5.05K Sell
25
-25
-50% -$5.67K ﹤0.01% 617
2022
Q4 		$10.9K Buy
+50
New +$10.9K ﹤0.01% 503

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.4B AUM 49.36% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Colonial Trust Advisors's CRL Position: Q2 2024 in Review

Colonial Trust Advisors sold out of Charles River Laboratories (CRL) in Q2 2024, closing a stake of 77 shares — an estimated $20.9K sold.

Colonial Trust Advisors first reported a position in CRL in Q4 2022 and held it in 6 quarters. The position peaked at $20.9K in Q1 2024. 665 funds tracked by Wall St. Rank hold CRL as of Q2 2024.

  • Colonial Trust Advisors reported no remaining Charles River Laboratories position as of Q2 2024 after selling out during the quarter.
  • Colonial Trust Advisors sold 77 Charles River Laboratories shares in Q2 2024, an estimated $20.9K.
  • Colonial Trust Advisors first reported a position in Charles River Laboratories in Q4 2022 and held it in 6 quarters.
  • Colonial Trust Advisors's Charles River Laboratories position peaked at $20.9K in Q1 2024.
  • 665 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2024.

Based on Colonial Trust Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.